Efficacy and Safety of New and Emerging Drugs for COVID-19: Favipiravir and Dexamethasone

PURPOSE OF REVIEW: The widespread respiratory disease of virus known as severe acute respiratory syndrome–coronavirus 2019 (SAR-CoV-2) had infected more than 200 countries and caused pandemic and havoc in the world. RECENT FINDINGS: The genome of the virus was sequenced rapidly to study its mechanis...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Curr Pharmacol Rep
Autori principali: Sood, Shivani, Bhatia, Gurpreet Kaur, Seth, Prachi, Kumar, Pawan, Kaur, Jagjit, Gupta, Vidisha, Punia, Sandeep, Tuli, Hardeep Singh
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer International Publishing 2021
Soggetti:
Clinical Pharmacology (L Brunetti, Section Editor)
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7889701/
https://ncbi.nlm.nih.gov/pubmed/33619447
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40495-021-00253-w
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi